Similar articles

• ACP Journal Club. Review: intensive glucose control reduces surrogate, but not clinical, renal outcomes in type 2 diabetes.

  Corbett EC Jr. Corbett EC Jr. Ann Intern Med. 2012 Nov 20;157(10):JC5-6. doi: 10.7326/0003-4819-157-10-201211200-02006. Ann Intern Med. 2012. PMID: 23165682 No abstract available.
• ACP Journal Club. Review: Dabigatran increases MI and reduces mortality compared with warfarin, enoxaparin, or placebo.

  Cairns J. Cairns J. Ann Intern Med. 2012 Jun 19;156(12):JC6-11. doi: 10.7326/0003-4819-156-12-201206190-02011. Ann Intern Med. 2012. PMID: 22711112 No abstract available.
• ACP Journal Club. Review: Intensive glucose control reduced some CV events but did not change mortality in type 2 diabetes.

  Lipscombe LL. Lipscombe LL. Ann Intern Med. 2009 Sep 15;151(6):JC3-6. doi: 10.7326/0003-4819-151-6-200909150-02006. Ann Intern Med. 2009. PMID: 19755352 No abstract available.
• ACP Journal Club. Review: Intensive glucose lowering does not reduce mortality in type 2 diabetes.

  Lingegowda V. Lingegowda V. Ann Intern Med. 2011 Dec 20;155(12):JC6-4. doi: 10.7326/0003-4819-155-12-201112200-02004. Ann Intern Med. 2011. PMID: 22184705 No abstract available.
• ACP journal club. Intensive glucose control increased mortality and did not prevent CV events compared with standard glucose control in type 2 diabetes.

  Grubina R, Smith SA. Grubina R, et al. Ann Intern Med. 2011 May 17;154(10):JC5-02. doi: 10.7326/0003-4819-154-10-201105170-02002. Ann Intern Med. 2011. PMID: 21576520 No abstract available.